MedTrace Logo

The Effect of Post-Scenario Debriefing and Rapid Cycle Deliberate Practice in Anaphylactic Shock Training on Nursing Students' Knowledge, Performance, Self-Confidence, and Satisfaction

NCT07388329 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-02-10

No results posted yet for this study

Summary

This study aims to examine the effect of rapid cycle deliberate practice (RCDP) on nursing students' knowledge, performance, self-confidence, and satisfaction levels regarding anaphylactic shock management. Based on a randomized controlled study design, the study will compare third-year nursing students in terms of RCDP application with traditional analysis methods performed at the end of a scenario. Students, divided into intervention and control groups, will have their knowledge levels, simulation performance, self-confidence, and satisfaction assessed using various scales. The retention of learning and students' subjective learning experiences will also be included in the research. The outcome of this study will determine whether RCDP is an effective method for improving critical clinical decision-making and emergency management skills in nursing students.

Conditions

  • Nursing Students
  • Nursing Education
  • Simulation Based Learning

Interventions

BEHAVIORAL

rapid cycle deliberate practice

Unlike traditional debriefing, feedback is provided by pausing the scenario within the simulation. Then the part of the script up to the pause point is repeated.

BEHAVIORAL

Post-scenario debriefing

Debriefing is performed at the end of the simulation scenario.

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-15
Primary Completion
2026-06-30
Completion
2026-07-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07388329 on ClinicalTrials.gov